Allergy Testing

Bronchodilator Reversibility Testing

Bronchodilator reversibility testing measures airway response to inhaled medication — key for asthma diagnosis.

What This Test Evaluates

  • Airway reversibility (asthma indicator)
  • Response to bronchodilator medication
  • Distinguishing asthma from COPD
  • Fixed vs. reversible airflow obstruction

Who May Need This Test

  • Patients with suspected asthma
  • Patients with suspected COPD
  • Patients with airflow obstruction on spirometry
  • Patients with unclear respiratory diagnosis

Preparation Requirements

  • Stop short-acting bronchodilators 4–6h before
  • Stop long-acting bronchodilators as directed
  • Inform of all respiratory medications
  • No smoking before test

Procedure

  • Baseline spirometry performed
  • Administer bronchodilator (salbutamol/albuterol)
  • Wait 15–30 minutes
  • Repeat spirometry
  • Compare pre and post values

Interpretation

  • Significant improvement (≥12% and ≥200ml FEV1 increase) suggests asthma
  • Minimal improvement suggests fixed obstruction (COPD)
  • Reversibility supports asthma diagnosis
  • Lack of reversibility does not exclude asthma (may need challenge testing)

Limitations

  • May be negative in well-controlled or mild asthma
  • Requires patient effort for spirometry
  • Cannot distinguish all phenotypes
  • May need bronchoprovocation testing if negative but suspicion remains

Follow-Up

  • Guide asthma vs. COPD diagnosis
  • Determine treatment approach
  • Assess response to bronchodilator therapy
  • Further testing if results inconclusive

Related Pages

Ready to get answers?

Book a specialist consultation to discuss your symptoms and treatment options.

Medical disclaimer: This page is for educational purposes and does not constitute medical advice. Individual diagnosis and treatment require consultation with a qualified healthcare professional. If you are experiencing a medical emergency, seek immediate care.